Perspectives
CME Article: State of Maryland Sickle Cell Disease Follow-up Program: Evolution of a Public Health Program
Abstract
All infants born in Maryland are tested for sickle cell disease (SCD) and other hemoglobinopathies via blood spot screening by the Newborn Screening Program (NBS). An NBS nurse(s), upon receiving a positive blood spot for SCD, contacts the pediatrician of record to inform him or her of the results, requests a second blood screen to be done at the first newborn visit, and requests the initiation of prophylactic penicillin or another antibiotic as warranted. Once the second screen and prophylactic antibiotic are confirmed, the case is transferred to Maryland’s Sickle Cell Disease Followup Program (SCDFP).This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
